Tenaya Therapeutics Inc.
TNYA | NASDAQ
$0.69
+$0.02 (+2.40%)
Sep 22, 2026, 1:25 PM ET · Market open
Market Data
Market Cap $146.21M
Enterprise Value $72.08M
Beta 2.78
Average Volume 3.14M
Shares Outstanding (Diluted) 217.57M
Shares Change YoY 33.65%
Institutional Ownership 25.04%
Exchange NASDAQ
ISIN US87990A1060
Price Performance
Price Change 1M -4.3%
Price Change 3M -7.7%
Price Change 6M -7.3%
Price Change YTD -8.8%
Price Change 1Y -52.5%
Price Change 3Y -76.3%
Price Change 5Y -96.4%
1M CAGR (ann.) -7.3%
1Y CAGR (ann.) -49.0%
5Y CAGR (ann.) -50.3%
All-Time CAGR -45.5%
Valuation
PE Ratio -1.26
Forward PE 10.73
PEG Ratio -0.02
Forward PEG 0.05
PS Ratio 109.52
Forward PS 73.10
PB Ratio 2.11
P/FCF Ratio -2.04
P/Adj. FCF Ratio -1.75
P/OCF Ratio -2.03
EV/Sales 53.99
EV/EBIT -0.70
EV/EBITDA -0.75
EV/FCF -1.00
Earnings Yield -79.1%
FCF Yield -49.1%
Adj. FCF Yield -57.2%
Financial Health
Net Cash $78.09M
Total Debt $3.95M
Cash & Short-Term Investments $78.09M
Total Assets $93.54M
Current Ratio 4.52
Quick Ratio 4.52
Debt / Equity Ratio 0.06
Debt / EBITDA -0.04
Debt / FCF -0.06
OCF / Debt -18.12
Interest Coverage 0.00
Altman Z-Score -9.12
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 263.7%
Operating Profit Margin -7929.9%
EBITDA Margin -7188.1%
Net Profit Margin -7724.0%
FCF Margin -5380.8%
Adj. FCF Margin -6262.6%
SBC / Revenue 881.8%
SBC Impact (per share) -16.4%
Returns
Return on Assets -110.2%
Return on Equity -108.0%
Return on Invested Capital -136.8%
Return on Capital Employed -142.1%
Return on Tangible Assets -110.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 51.0%
EPS CAGR 5Y 35.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 16.3%
FCF CAGR 5Y 13.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y 164.2%
Revenue Growth Next 3Y 197.4%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.10
EPS Growth Est (next Q) -16.7%
Revenue Est (next Q) $800K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2.33
Price Target Upside 247.8%
Cash Flow
Operating Cash Flow $-71.56M
Free Cash Flow $-71.83M
Adj. Free Cash Flow $-83.61M
FCF Per Share -$0.33
OCF Per Share -$0.33
OCF/S Ratio -5360.2%
Income Statement
Revenue $1.34M
Gross Profit $3.52M
Operating Income $-105.86M
EBITDA $-95.96M
Net Income $-103.12M
EPS (Diluted) -$0.53
Revenue / Employee $19.07K
Profit / Employee $-1.47M
Employees 70
Add to Watchlist
Select watchlists to add or remove TNYA